Treatment-Resistant Depression and Ketamine Response in a Patient With Bilateral Amygdala Damage

Am J Psychiatry. 2019 Dec 1;176(12):982-986. doi: 10.1176/appi.ajp.2019.18101219.

Authors

Dirk Scheele¹, Sophia Zimbal¹, Justin S Feinstein¹, Achilles Delis¹, Claudia Neumann¹, Clemens Mielacher¹, Alexandra Philipsen¹, René Hurlemann¹

Affiliation

¹ Division of Medical Psychology (Scheele, Zimbal, Mielacher, Hurlemann), Department of Anesthesiology (Delis, Neumann), and Department of Psychiatry (Philipsen, Hurlemann), University Hospital, Bonn, Germany; Laureate Institute for Brain Research, Tulsa, Okla. (Feinstein); and Department of Psychiatry, University of Oldenburg Medical Campus, Bad Zwischenahn, Germany (Hurlemann).

PMID: 31787017
DOI: 10.1176/appi.ajp.2019.18101219

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Amygdala / pathology*
Depressive Disorder, Major / drug therapy*
Depressive Disorder, Major / pathology*
Depressive Disorder, Treatment-Resistant / drug therapy*
Depressive Disorder, Treatment-Resistant / pathology*
Excitatory Amino Acid Antagonists / therapeutic use
Female
Humans
Ketamine / therapeutic use*

Substances

Excitatory Amino Acid Antagonists
Ketamine